Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients

NCT03568383 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

5832

Enrollment

NIH

Sponsor class

Conditions

Tuberculosis, MDR

Interventions

DRUG: Delamanid (DLM)
DRUG: Isoniazid (INH)
DIETARY_SUPPLEMENT: Pyridoxine (vitamin B6)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]